Wang, F.; Han, Y.; Sang, W.; Wang, L.; Liang, X.; Wang, L.; Xing, Q.; Guo, Y.; Zhang, J.; Zhang, L.;
et al. In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment. Cells 2022, 11, 2495.
https://doi.org/10.3390/cells11162495
AMA Style
Wang F, Han Y, Sang W, Wang L, Liang X, Wang L, Xing Q, Guo Y, Zhang J, Zhang L,
et al. In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment. Cells. 2022; 11(16):2495.
https://doi.org/10.3390/cells11162495
Chicago/Turabian Style
Wang, Feifei, Yafan Han, Wanyue Sang, Lu Wang, Xiaoyan Liang, Liang Wang, Qiang Xing, Yankai Guo, Jianghua Zhang, Ling Zhang,
and et al. 2022. "In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment" Cells 11, no. 16: 2495.
https://doi.org/10.3390/cells11162495
APA Style
Wang, F., Han, Y., Sang, W., Wang, L., Liang, X., Wang, L., Xing, Q., Guo, Y., Zhang, J., Zhang, L., Zukela, T., Xiaokereti, J., Lu, Y., Zhou, X., Tang, B., & Li, Y.
(2022). In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment. Cells, 11(16), 2495.
https://doi.org/10.3390/cells11162495
